The following clinical characteristics of depression patients with a codiagnosis of BPD have been described: lower age at onset of MDD; higher severity of depressive symptoms; lower level of social functioning; chronic MDD and repeated hospitalization; more common suicidal ideation and behaviour; history of physical or sexual abuse in childhood; and higher cooccurrence of phobias, eating disorders, and alcohol and cannabis abuse (2, (9) (10) (11) (12) (13) (14) (15) (16) (17) .
Replication of these findings is needed to determine whether the clinical picture of MDD is significantly influenced by concomitant BPD. If this is the case, careful identification of personality disorders should be considered in the diagnostic assessment of depressive disorders. The present study aimed to further analyze data on this topic by comparing 2 groups of depression patients: those with concomitant BPD and those with other Axis II codiagnoses.
Material and Methods
We included in this study 119 consecutive outpatients (aged 18 years and over) who had a diagnosis of personality disorder and a codiagnosis of MDD. Patients attended the Service for Personality Disorders, Unit of Psychiatry, at the University of Turin. Diagnoses were made by an expert clinician according to DSM-IV-TR criteria (18) and were confirmed with the Structured Clinical Interview for DSM-IV disorders (SCID, 19, 20) . Subjects were excluded if they had a current or previous diagnosis of delirium, dementia, amnestic disorder, or other cognitive disorders; schizophrenia or other psychotic disorders; or bipolar disorders. Each patient participated voluntarily in this study after providing written informed consent. Patients were divided into 2 subgroups: those with a diagnosis of BPD and those with a different Axis II diagnosis.
Patients were tested with the following instruments: · A semistructured interview to assess demographic and clinical features (age, sex, age at onset and duration of MDD, number of major depressive episodes, history of self-mutilating behaviours and substance abuse, and occurrence of mood and anxiety disorders in first-degree relatives). All data were confirmed by clinical chart review and by a close informant, when available.
· The SCID, to determine Axis I comorbidity. 
Results
The patient sample had a mean age of 37.23 years, SD 14.67; there were 74 women (62.2%) and 45 men (37.8%).
In total, 45 patients (37.8%) had a diagnosis of BPD, while 74 patients (62.2%) met criteria for the following other personality disorders: obsessive-compulsive (n = 20, 16.8%), avoidant (n = 17, 14.3%), dependent (n = 13, 10.9%), histrionic (n = 11, 9.2%), narcissistic (n = 10, 8.4%), paranoid (n = 8, 6.7%), schizotypal (n = 6, 5%), and schizoid (n = 4, 3.4%). Table 1 reports Pearson's chi-square test comparisons of categorical variables between subgroups. In the BPD subgroup, we found more common occurrence of Axis I comorbidity (P = 0.042), mood and anxiety disorders in first-degree relatives (P = 0.016), self-mutilating behaviours (P = 0.0005), substance abuse (P = 0.008), verbal or emotional abuse in childhood (P = 0.008), and physical abuse in childhood (P = 0.049). Table 2 shows mean (SD) values of continuous variables and comparisons of the 2 subgroups with Student's t test. Patients with BPD had a lower mean age (P = 0.019), an earlier age at onset of MDD (P = 0.025), a lower SOFAS score (P = 0.0005), and higher scores on the HARS (P = 0.021), ZSDS (P = 0.007), and SDS (P = 0.0005).
Multiple regression showed that 5 variables were significantly related to the number of criteria for BPD: the ZSDS score (P = 0.0005), self-mutilating behaviours (P = 0.001), and occurrence of mood disorders in first-degree relatives (P = 0.01) were positively related, whereas the SOFAS score (P = 0.0005) and age at onset of MDD (P = 0.006) were negatively related (Table 3 ).
Discussion
Our data contribute to outlining differential characteristics of patients with coexisting MDD and BPD, compared with depression patients with other Axis II codiagnoses. Results of regression analysis indicate that the number of BPD criteria is related to earlier age at onset of MDD, more serious patient-rated depressive symptoms, worse clinician-rated global functioning, more common history of self-mutilating behaviours, and higher occurrence of mood disorders in first-degree relatives.
Our findings concerning age at onset of MDD, level of global functioning, and frequency of self-mutilating behaviours are consistent with previous studies (9) (10) (11) 15, 16) . The association we found between number of BPD criteria and prevalence of mood disorders in the families of our depression patients can also be considered a substantial confirmation of preceding reports. For example, several authors have reported an increased rate of mood disorders in the relatives of BPD patients (1, 27, 28) and have suggested that it could be the consequence of coexisting affective syndromes. Riso and colleagues pointed out that the rates of mood disorders in the relatives of BPD probands were similar to rates found in a mood disorder control group (29) . Similarly, our investigation of a sample of patients with a diagnosis of MDD found that coexisting BPD features were related to a family history of mood disorders. Despite some differences in methods among studies, available data implicate a strong familial link between BPD and mood disorders, suggesting that overlapping etiologic factors be considered.
A notable finding in our study is that the number of BPD criteria is only significantly related to the severity of depressive symptoms when measured by the patient, not by the clinician. This result appears discordant with a previous investigation by Comtois and colleagues, who reported that both a clinician-rated scale and a self-report measure of depressive symptoms were significantly related to BPD (2) . If the difference that we found between the 2 types of scale is confirmed, a possible explanation could be that BPD patients experience and express depression with a dramatic and emphasized modality.
In conclusion, results of our study indicate that, compared with MDD patients having other Axis II codiagnoses, MDD patients with coexisting BPD are characterized by distinct clinical features. These include earlier onset and more severe depression, worse social impairment, more pronounced self-aggressiveness, and a stronger familial association with mood disorders. These differential characteristics may have diagnostic and therapeutic implications. need for an accurate assessment of personality disorders in depression patients to identify cases with concomitant BPD and to reduce the incidence of complications such as selfmutilating behaviours or suicide attempts and loss of social abilities. The search for BPD should be particularly recommended in depression patients with a family history of mood disorders. Moreover, detection of BPD could be considered a predictive factor for early-onset MDD and induce clinicians to provide adequate preventive treatment.
A limitation of our study is that we collected clinical data retrospectively by interviewing patients on their psychiatric history. In particular, childhood abuse was identified from patients' memories. The validity of retrospective methods to collect data on autobiographical events remains controversial, although some authors regard patients' reports as sufficiently accurate (30, 31) . Another limitation is that data concerning previous and ongoing treatments were not analyzed, because there was considerable heterogeneity in drug and psychosocial interventions. Résultats : La gravité du TPL était positivement reliée au score à la ZSDS, aux comportements d'automutilation, et à la présence de troubles de l'humeur chez des parents du premier degré; elle était négativement reliée au score à la SOFAS et à l'âge de l'apparition du TDM.
Conclusions : Les patients souffrant de TDM et de TPL comorbides présentent des caractéristiques différentielles qui indiquent un état plus sérieux et incapacitant, et un fort lien familial avec des troubles de l'humeur, que ne le font les patients dépressifs présentant d'autres co-diagnostics de l'axe II.
